The ASA, the American Academy of Pediatrics and the Society for Pediatric Anesthesia called the research “a high priority for the specialty in order to provide reassurance that needed procedures can be performed as safely as possible.”
The organizations said if the potential for brain injury exists, anesthesiologists need to understand the mechanism of the injury so they can develop ways to prevent or minimize damage.
Read the ASA, AAP and SPA joint letter to the FDA.
Read more on anesthesia:
–Boston Medical Center Anesthesiologist Receives WHO Commendation for Pulse Oximetry Training Video
–FDA Panel to Discuss Cognitive Effects of Anesthesia on Young Children
–Study Examines Effect of Anesthesia Depth on Long-Term Mortality
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
